Back to top
more

Johnson & Johnson (JNJ)

(Delayed Data from NYSE)

$174.72 USD

174.72
8,241,747

+0.30 (0.17%)

Updated Aug 14, 2025 04:00 PM ET

After-Market: $175.51 +0.79 (0.45%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 246)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and J&J

by Zacks Equity Research

Pfizer, BioNTech, Moderna and J&J are included in this analyst blog.

Zacks Equity Research

Is a Beat Likely for AbbVie (ABBV) This Earnings Season?

by Zacks Equity Research

AbbVie's (ABBV) fourth-quarter results are expected to reflect the impact of strong demand for immunology drugs, aesthetics and cosmetics. Investors are likely to focus on any update related to the guidance for 2022.

Kinjel Shah headshot

Pharma Stock Roundup: J&J Q4 Earnings, FDA's Rejection of PFE, MRK Pipeline Drugs

by Kinjel Shah

J&J (JNJ) reports mixed fourth-quarter results. FDA issues CRL to Merck (MRK) and Pfizer's (PFE) pipeline candidates. FDA approves AbbVie's (ABBV) Skyrizi for a second indication.

Zacks Equity Research

Pfizer (PFE), BioNTech Begin Omicron-Based COVID-19 Jab Study

by Zacks Equity Research

Pfizer (PFE) and BioNTech (BNTX) announce that the first participants in a clinical study on its Omicron-specific COVID-19 vaccine candidate have been dosed.

Zacks Equity Research

Company News for Jan 26, 2022

by Zacks Equity Research

Companies in The News Are: JNJ,LMT,ERIC,MMM

Zacks Equity Research

Smith+Nephew (SNN) to Acquire Orlando-Based Engage Surgical

by Zacks Equity Research

Smith+Nephew's (SNN) acquisition of Engage Surgical reinforces its growth strategy while expanding its Orthopaedic Reconstruction product line.

Zacks Equity Research

Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for VIG

Zacks Equity Research

Markets Await More Earnings Data

by Zacks Equity Research

Markets Await More Earnings Data

Zacks Equity Research

J&J (JNJ) Q4 Earnings Beat Estimates by a Penny, Sales Miss

by Zacks Equity Research

J&J (JNJ) reports mixed fourth-quarter results. It beats estimates for earnings but misses the same for sales.

    Mark Vickery headshot

    Market Selling Resumes; GE, J&J Miss on Revenues

    by Mark Vickery

    The Dow is -250 points at the hour, while the Nasdaq is down -260; the S&P 500 has dropped -60 points from yesterday's close.

    Zacks Equity Research

    Johnson & Johnson (JNJ) Surpasses Q4 Earnings Estimates

    by Zacks Equity Research

    Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 0.47% and 1.77%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

    Mark Vickery headshot

    Did Stock Markets Touch Bottom Today?

    by Mark Vickery

    We saw the indexes come roaring back, particularly in the last hour of regular trading, which surged each major index into the green.

    Daniel Laboe headshot

    S&P 500 Enters Correction Territory As Investors De-Risk Ahead of Fed Meeting & Big Tech Earnings

    by Daniel Laboe

    Bears have taken market control but the Fed's policy decision coupled with big tech earnings could reverse this negative narrative

    Zacks Equity Research

    Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for QUS

    Zacks Equity Research

    J&J (JNJ) to Set the Stage for Pharma Sector Q4 Earnings

    by Zacks Equity Research

    J&J's (JNJ) Pharma segment is expected to have performed above the market. It remains to be seen if sales improved in the Medical Devices segment in the fourth quarter.

    Zacks Equity Research

    Should Vanguard Value ETF (VTV) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for VTV

    Zacks Equity Research

    Johnson & Johnson (JNJ) Stock Moves -0.31%: What You Should Know

    by Zacks Equity Research

    In the latest trading session, Johnson & Johnson (JNJ) closed at $166.58, marking a -0.31% move from the previous day.

    Zacks Equity Research

    Should WisdomTree U.S. Total Dividend ETF (DTD) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for DTD

    Neena Mishra headshot

    Why You Should Invest in Dividend Growth ETFs Now

    by Neena Mishra

    We highlight 3 ultra-cheap ETFs that focus on high quality dividend payers

    Zacks Equity Research

    The Zacks Analyst Blog Highlights: Apple Inc., Johnson & Johnson and McDonald's Corp

    by Zacks Equity Research

    Apple Inc., Johnson & Johnson and McDonald's Corp are highlighted in this analyst blog article.

    Zacks Equity Research

    Is WisdomTree U.S. LargeCap Dividend ETF (DLN) a Strong ETF Right Now?

    by Zacks Equity Research

    Smart Beta ETF report for DLN

    Sheraz Mian headshot

    Q4 Earnings Update and Analyst Reports for Apple, JNJ & McDonald's

    by Sheraz Mian

    In addition to a real-time Q4 scorecard, today's article features new research reports Apple (AAPL), Johnson & Johnson (JNJ), McDonald's (MCD) and others.

    Zacks Equity Research

    Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

    by Zacks Equity Research

    Sector ETF report for FHLC

    Zacks Equity Research

    Should Schwab U.S. LargeCap Value ETF (SCHV) Be on Your Investing Radar?

    by Zacks Equity Research

    Style Box ETF report for SCHV

    Zacks Equity Research

    Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

    by Zacks Equity Research

    In the latest trading session, Johnson & Johnson (JNJ) closed at $171.25, marking a -1.06% move from the previous day.